Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19

BACKGROUND: Metabolic associated fatty liver disease (MAFLD) is associated with complications and mortality in patients with coronavirus disease 2019 (COVID-19). However, there are no prognostic scores aimed to evaluate the risk of severe disease specifically in patients with MAFLD, despite its high...

Descripción completa

Detalles Bibliográficos
Autores principales: Macías-Rodríguez, Ricardo Ulises, Solís-Ortega, Alberto Adrián, Ornelas-Arroyo, Victoria J, Ruiz-Margáin, Astrid, González-Huezo, Maria Sarai, Urdiales-Morán, Nestor A, Román-Calleja, Berenice M, Mayorquín-Aguilar, Juan M, González-Regueiro, José A, Campos-Murguía, Alejandro, Toledo-Coronado, Israel Vicente, Chapa-Ibargüengoitia, Mónica, Valencia-Peña, Bernardo, Martínez-Cabrera, Carlos Fernando, Flores-García, Nayelli C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611707/
https://www.ncbi.nlm.nih.gov/pubmed/36312835
http://dx.doi.org/10.3748/wjg.v28.i37.5444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611707/
https://www.ncbi.nlm.nih.gov/pubmed/36312835
http://dx.doi.org/10.3748/wjg.v28.i37.5444

Ejemplares similares